Hony Capital takes home $528m from CSPC placement
Chinese private equity firm Hony Capital sold a HK$4.095bn ($528m) stake in CSPC Pharmaceutical Group on August 28 by pricing at the bottom of guidance in what was its fourth stake reduction in the company in 16 months.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: